Advertisement

FDA Head Asks for Investigation Into Alzheimer Disease Drug Approval

0

Request follows reports that Biogen and the FDA held off-the-books meetings before the drug's approval that may have violated FDA protocol

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Racial, Ethnic Disparities Explored in Subjective Cognitive Decline

0

More Black and Hispanic adults than White adults report subjective cognitive decline at age 45 to 54 years

New Rx Instructions Tighten Use of Controversial Alzheimer Disease Drug

0

Major changes to prescribing instructions are rare, especially so soon after approval; change could curb the drug's use

Cytisine Not Noninferior to Varenicline for Smoking Cessation

0

Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group

Link Found for Weight-, Shape-Related Bullying, Eating Disorder Behaviors

0

Frequency of bullying positively linked to purging, muscularity-oriented behavior, but not dietary restriction, binge eating

Patient Engagement May Not Drive Return to In-Person Visits

0

Findings seen among patients receiving letter during reopening following cancellation of in-person care during COVID-19

Behavioral, Biological Links Studied in Eating Disorders

0

Functional brain imaging used to assess brain reward response and ventral striatal-hypothalamic circuitry in young women with eating disorders

Cognitive, Functional Decline Detected Prior to Stroke

0

Patients with stroke have steeper declines in the 10 years before stroke compared with stroke-free controls